Jan Bolinder
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Genetics top 0.2%
- Diabetes and associated disorders
Papers in
-
- Renal Transplantation Outcomes and Treatments 23
-
- Diabetes Management and Research 76
- Diabetes Treatment and Management 28
- Co-authors
- Peter ArnerJan ÖstmanEva ToftPeter EngfeldtTadej BattelinoÖsten LjunggrenJohn WildingShamik Parikh
- Journals
- Diabetologia (27 papers)Diabetes (15 papers)The Journal of Clinical Endocrinology & Metabolism (15 papers)Diabetes Technology & Therapeutics (12 papers)Diabetes Care (12 papers)
- Partner nations
- SwedenGermanyUnited States
In The Last Decade
Jan Bolinder
189 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Endocrinology, Diabetes and Metabolism 6.2k
- Genetics 3.2k
- Surgery 4.2k
- Transplantation 254
- Physiology 2.2k
Countries citing papers authored by Jan Bolinder
This map shows the geographic impact of Jan Bolinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Bolinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Bolinder more than expected).
Fields of papers citing papers by Jan Bolinder
This network shows the impact of papers produced by Jan Bolinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Bolinder. The network helps show where Jan Bolinder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Bolinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2021 | 36 | |
| 4 | Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections Hit paper breakdown → | 2017 | 529 |
| 5 | 2014 | 84 | |
| 6 | 2012 | 0 | |
| 7 | 2010 | 100 | |
| 8 | 2008 | 110 | |
| 9 | 2006 | 62 | |
| 10 | 2006 | 11 | |
| 11 | 2004 | 32 | |
| 12 | Islet antibodies at diagnosis versus beta-cell function eight years later in young adult patients with diabetes. | 2002 | 2 |
| 13 | 1998 | 3 | |
| 14 | 1997 | 2 | |
| 15 | 1994 | 11 | |
| 16 | Long-term glucose control after pancreatic transplantation with enteric exocrine diversion. | 1992 | 0 |
| 17 | 1991 | 10 | |
| 18 | 1991 | 21 | |
| 19 | 1990 | 11 | |
| 20 | Insulin binding to isolated human omental and sub cutaneous fat cells | 1981 | 4 |
About Jan Bolinder
Jan Bolinder is a scholar working on Transplantation, Endocrinology, Diabetes and Metabolism, Physiology, Genetics and Surgery, having authored 193 papers that have together received 10.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (76 papers), Pancreatic function and diabetes (73 papers), Diabetes and associated disorders (56 papers), Adipose Tissue and Metabolism (42 papers), Diabetes Treatment and Management (28 papers), Renal Transplantation Outcomes and Treatments (23 papers), Muscle metabolism and nutrition (21 papers) and Metabolism, Diabetes, and Cancer (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.2k citations), Genetics (3.2k citations), Surgery (4.2k citations), Transplantation (254 citations) and Physiology (2.2k citations). Jan Bolinder has collaborated with scholars based in Sweden, Germany and United States. Frequent co-authors include Peter Arner, Jan Östman, Eva Toft, Peter Engfeldt, Tadej Battelino, Östen Ljunggren, John Wilding, Shamik Parikh, Jennifer Sugg and Jens Kröger. Their work appears in journals such as Diabetologia, Diabetes, The Journal of Clinical Endocrinology & Metabolism, Diabetes Technology & Therapeutics and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.